期刊文献+

Identifying timing and risk factors for early recurrence of resectable rectal cancer: A single center retrospective study

下载PDF
导出
摘要 BACKGROUND Colorectal cancer is a common malignancy and various methods have been introduced to decrease the possibility of recurrence.Early recurrence(ER)is related to worse prognosis.To date,few observational studies have reported on the analysis of rectal cancer.Hence,we reported on the timing and risk factors for the ER of resectable rectal cancer at our institute.AIM To analyze a cohort of patients with local and/or distant recurrence following the radical resection of the primary tumor.METHODS Data were retrospectively collected from the institutional database from March 2011 to January 2021.Clinicopathological data at diagnosis,perioperative and postoperative data,and first recurrence were collected and analyzed.ER was defined via receiver operating characteristic curve.Prognostic factors were evaluated using the Kaplan–Meier method and Cox proportional hazards modeling.RESULTS We included 131 patients.The optimal cut off value of recurrence-free survival(RFS)to differentiate between ER(n=55,41.9%)and late recurrence(LR)(n=76,58.1%)was 8 mo.The median post-recurrence survival(PRS)of ER and LR was 1.4 mo and 2.9 mo,respectively(P=0.008)but PRS was not strongly associated with RFS(R^(2)=0.04).Risk factors included age≥70 years[hazard ratio(HR)=1.752,P=0.047],preoperative concurrent chemoradiotherapy(HR=3.683,P<0.001),colostomy creation(HR=2.221,P=0.036),and length of stay>9 d(HR=0.441,P=0.006).CONCLUSION RFS of 8 mo was the optimal cut-off value.Although ER was not associated with PRS,it was still related to prognosis;thus,intense surveillance is recommended.
出处 《World Journal of Gastrointestinal Surgery》 SCIE 2024年第9期2842-2852,共11页 世界胃肠外科杂志(英文版)(电子版)
  • 相关文献

参考文献2

二级参考文献20

  • 1Jér?me Galon,Anne Costes,Fatima Sanchez-Cabo,Amos Kirilovsky,Bernhard Mlecnik,Christine Lagorce-Pagès,Marie Tosolini,Matthieu Camus,Anne Berger,Philippe Wind,Franck Zinzindohoué,Patrick Bruneval,Paul-Henri Cugnenc,Zlatko Traja.Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome. Science . 2006
  • 2Pugh R N,Murray-Lyon I M,Dawson J L,Pietroni M C,Williams R.Transection of the oesophagus for bleeding oesophageal varices. The British journal of surgery . 1973
  • 3F.Xavier Bosch,Josepa Ribes,Mireia Díaz,Ramon Cléries.Primary liver cancer: Worldwide incidence and trends[J].Gastroenterology.2004(5)
  • 4A. Thelen,C. Benckert,H.‐M. Tautenhahn,H.‐M. Hau,M. Bartels,J. Linnemann,J. Bertolini,M. Moche,C. Wittekind,S. Jonas.Liver resection for hepatocellular carcinoma in patients without cirrhosis[J].Br J Surg.2012(1)
  • 5Wan Yee Lau,Eric C. H. Lai,Thomas W. T. Leung,Simon C. H. Yu.Adjuvant Intra-arterial Iodine-131-labeled Lipiodol for Resectable Hepatocellular Carcinoma: A Prospective Randomized Trial—Update on 5-Year and 10-Year Survival[J].Annals of Surgery.2008(1)
  • 6Jonathan D Schwartz,Myron Schwartz,John Mandeli,Max Sung.Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials[J].Lancet Oncology.2002(10)
  • 7Makuuchi M,Kosuge T,Takayama T,Yamazaki S,Kakazu T,Miyagawa S,Kawasaki S.Surgery for small liver cancers. Seminars in Surgical Oncology . 1993
  • 8Josep M Llovet,Andrew Burroughs,Jordi Bruix.Hepatocellular carcinoma[J]. The Lancet . 2003 (9399)
  • 9Seldinger S I.Catheter replacement of needle in percutaneous arteriography: new technique. Acta Radiologica . 1953
  • 10A. K.Singal,D. H.Freeman Jr,B. S.Anand.Meta‐analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma[J]. Alimentary Pharmacology & Therapeutics . 2010 (7)

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部